Skip to main content

Schrier Derek C's Form 4 filing

Tabula Rasa HealthCare, Inc.TRHC · filed Nov 14, 2023

Accession no.
0000921895-23-002642
Filed
Nov 14, 2023, 6:00 PM ET
Trade date
Nov 3-7, 2023
Filing delay
11 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 11 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schrier Derek CCIK 0001250078Director, 10% Owner
Indaba Capital Fund, L.P.CIK 0001516452Director
Indaba Capital Management, L.P.CIK 0001524362Director, 10% Owner
Ic GP, LLCCIK 0001596505Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 3, 2023Common StockDReturned to the companyDisposed−6,599,966$10.50F2,F3−$69,299,6430Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 6, 2023Common StockSSaleDisposed−965,020$67,243,500.00−$4,538,936,250,000,000317,785IndirectPrice outlier
Nov 7, 2023Common StockSSaleDisposed−317,785$22,145,756.00−$492,255,864,368,0000IndirectPrice outlier

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock ("Common Stock") issued and outstanding immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to $10.50 per share, without interest (the "Merger Consideration").

Referenced by the price of 1 transaction in Table I.

F3

Pursuant to the Merger Agreement, at the Effective Time, each outstanding (i) (A) restricted stock unit that was subject solely to time-based vesting conditions (each, a "Company RSU"), whether vested or unvested, and (B) share of Common Stock that was subject to vesting, repurchase or forfeiture (each, a "Company Restricted Share"), and (ii) restricted stock unit that was subject to both performance-based and time-based vesting conditions (each, a "Company PSU") that was vested as of immediately prior to the Effective Time but not yet settled or that automatically vested as a result of the Merger in accordance with its terms and without the exercise of discretion (each, a "Vested Company PSU"), in the case of each of clause (i) and (ii), was canceled and the holder thereof became entitled to receive an amount in cash equal to the Merger Consideration, provided that any Company PSU that did not constitute a Vested Company PSU was forfeited and canceled for no consideration.

Referenced by the price of 1 transaction in Table I.

Remarks

Derek C. Schrier, the Managing Member of IC GP, LLC, the general partner of the investment manager of Indaba Capital Fund, L.P., was a director of the Issuer. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Persons were deemed directors by deputization by virtue of their representation on the Board of Directors of the Issuer.

Read the full filing on SEC EDGAR (opens in a new tab)